Paragonix Technologies announced today that the FDA granted clearance for its next-generation BAROguard donor lung preservation system. BAROguard combines Paragonix’s existing advanced hypothermic preservation technology with automated continuous and active airway pressure control. This ensures that the system maintains an optimal temperature range and a clinically recommended inflation pressure range. It maintains this for donor […]
Transplants
TransMedics completes Summit Aviation acquisition
TransMedics (Nasdaq:TMDX) announced that it completed its previously announced acquisition of Summit Aviation. Andover, Massachusetts-based TransMedics initially announced its plans to acquire the U.S. charter flight operator on Aug. 1. It did not disclose financial terms at the time. With the closing of the deal, Summit founder Ben Walton joins the company as VP of […]
TransMedics proposes $300M offering
TransMedics (Nasdaq:TMDX) announced today that it intends to offer $300 million in convertible senior unsecured notes. Andover, Massachusetts-based TransMedics develops organ transplant technology. It offers FDA-approved lung and heart transplant technology, such as the OCS Heart that received pre-market approval in April 2022. The company’s offering remains subject to market and other conditions. The notes […]
TransMedics more than doubles revenue in Q1, raises guidance
TransMedics (Nasdaq:TMDX) shares rose this morning on first-quarter results that beat the consensus forecast. Shares of TMDX ticked up 1.2% at $78.78 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 0.3%. The Andover, Massachusetts-based organ transplant technology developer posted losses of […]
Study backs Paragonix lung preservation system
Paragonix Technologies announced today that study data demonstrated favorable outcomes related to its LUNGGuard organ preservation system. Cambridge, Massachusetts–based Paragonix evaluated its LUNGGuard against conventional ice-cold storage. The study used real-world, multi-center data collected from the GUARDIAN-Lung Registry. This analysis demonstrated a favorable influence from advanced lung preservation technology on post-transplant outcomes. Paragonix said it […]
Organ preservation tech developer Paragonix raises $24M series B
Paragonix Technologies announced today that it secured $24 million in a Series B financing round. Cambridge, Massachusetts-based Paragonix plans to use the funds to bolster its commercial footprint. That includes the ongoing extension of its clinical service offerings and inventory expansion. The company also plans to use funds to further advance its organ transplant innovations. […]
Baxter, Miromatrix partner on liver failure research
Baxter (NYSE:BAX) and Miromatrix Medical (Nasdaq:MIRO) today announced a collaborative research agreement on acute liver failure (ALF) treatments. As part of the collaboration, Eden Prairie, Minnesota-based Miromatrix created a new liver therapy. The therapy, called MiroLiverELAP, combines a Miromatrix single-use bioengineered liver with Baxter’s PrisMax system. Miromatrix designed the MiroLiverELAP to provide external support to […]
The 10 largest medtech employers — and what their employees really think
Employees of the 10 largest medtech employers are happy to be a part of companies having a positive impact on patient populations. That was one major takeaway as MassDevice compiled some current and former employee reviews posted on Glassdoor. Medtronic, Philips and Johnson & Johnson MedTech top the list of largest medtech employers. The 10 […]
Paragonix reaches milestone of 2,000 organs preserved, transported for transplantation
Paragonix Technologies announced today that it has preserved more than 2,000 donor organs for transport and transplantation. Cambridge, Massachusetts–based Paragonix designed its devices to combine clinically proven, stable, hypothermic preservation technology with an extensive clinical support network. There are digital tools for complete control over the process of organ tracking, monitoring and reporting. “We are […]
TransMedics grows sales 151% in Q2
TransMedics (NSDQ:TMDX) this week posted second-quarter financial results that beat the revenue consensus on Wall Street and missed earnings estimates. The Andover, Massachusetts-based organ preservation tech company reported losses of $11.5 million, or -41¢ per share, on sales of $20.5 million for the three months ended June 30, for a bottom-line loss of 8% on sales […]
Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection, […]
